2008Chinese Heart JournalRequires access

Effect of atorvastatin on myocardial injure and inflammatory reaction from PCI in patients with unstable angina pectoris

Wenyi Guo

Open publisher page 0 citations

Abstract

AIM To study the effect of atorvastatin on myocardial injure and inflammatory reaction from percutaneous coronary intervention(PCI)in patients with unstable angina pectoris. The markers of myocardial injure are CK-MB and cardiac troponin (cTnI). The marker of inflammatory reaction is high-sensitivity C-reactive protein (hs-CRP). METHODS The two treatment groups received atorvastatin 20 mg daily or non-atorvastatin 4 successive weeks before PCI,CK-MB,cTnI and hs-CRP of the blood from elbow vein were monitored before and 8 and 24 hours after the procedure of PCI. RESULTS The markers of two groups were elevated after PCI,however,the ascended values of CK-MB,cTnI and hs-CRP in the atrovastatin treatment group were significantly lower than those of the compared group(P0.01). CONCLUSION Administering 20 mg atorvastatin daily in 4 successive weeks before PCI can significantly reduce the myocardial injury and inflammatory reaction.

About this research paper

What this paper is about

AIM To study the effect of atorvastatin on myocardial injure and inflammatory reaction from percutaneous coronary intervention(PCI)in patients with unstable angina pectoris. The markers of myocardial injure are CK-MB and cardiac troponin (cTnI). The marker of inflammatory reaction is high-sensitivity C-reactive protein (hs-CRP). METHODS The two treatment groups received atorvastatin 20 mg daily or non-atorvastatin 4 successive weeks before PCI,CK-MB,cTnI and hs-CRP of the blood from elbow vein were monitored before and 8 and 24 hours after the procedure of PCI. RESULTS The markers of two groups were elevated after PCI,however,the ascended values of CK-MB,cTnI and hs-CRP in the atrovastatin treatment group were significantly lower than those of the compared group(P0.01). CONCLUSION Administering 20 mg atorvastatin daily in 4 successive weeks before PCI can significantly reduce the myocardial injury and inflammatory reaction.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM To study the effect of atorvastatin on myocardial injure and inflammatory reaction from percutaneous coronary intervention(PCI)in patients with unstable angina pectoris. The markers of myocardial injure are CK-MB and cardiac troponin (cTnI). The marker of inflammatory reaction is high-sensitivity C-reactive protein (hs-CRP). METHODS The two treatment groups received atorvastatin 20 mg daily or non-atorvastatin 4 successive weeks before PCI,CK-MB,cTnI and hs-CRP of the blood from elbow vein were monitored before and 8 and 24 hours after the procedure of PCI. RESULTS The markers of two groups were elevated after PCI,however,the ascended values of CK-MB,cTnI and hs-CRP in the atrovastatin treatment group were significantly lower than those of the compared group(P0.01). CONCLUSION Administering 20 mg atorvastatin daily in 4 successive weeks before PCI can significantly reduce the myocardial injury and inflammatory reaction.

Key concepts: Conventional PCI, Atorvastatin, Medicine, Percutaneous coronary intervention, Troponin I, Cardiology, Internal medicine, C-reactive protein

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of atorvastatin on myocardial injure and inflammatory reaction from PCI in patients with unstable angina pectoris — Research Paper | ScholarLens